| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/21/2014 | CA2441688C Compositions and methods useful for hcv infection |
| 01/21/2014 | CA2427257C Expression vectors able to elicit improved immune response and methods of using same |
| 01/16/2014 | WO2014011072A1 Producer of newcastle disease virus strain ndv/anas crecca/omsk/9/2010 usable for producing a candidate anti-cancer preparation on the basis thereof |
| 01/16/2014 | US20140017205 Bacteriophage and antibacterial composition comprising the same |
| 01/15/2014 | EP2683831A2 Rapid cell purification systems |
| 01/15/2014 | CN103517715A North american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 01/15/2014 | CN103509796A siRNA and mutant cloning vector prepared based on RNAi technology and rescue principle |
| 01/15/2014 | CN103509761A Recombinant porcine pseudorabies virus strain used for expression of porcine circovirus type II (PCV2) ORF2 gene, and preparation method thereof |
| 01/15/2014 | CN103509115A Nanometer antibodies to human cystatin C and application thereof |
| 01/15/2014 | CN103509094A Plant stress tolerance-related protein GmNF-YC9 as well as encoding gene and application thereof |
| 01/15/2014 | CN103509093A Plant stress tolerance-related protein GmNF-YC14 as well as encoding gene and application thereof |
| 01/15/2014 | CN102146418B Recombinant II type herpes simplex virus vector, preparation method of recombinant II type herpes simplex virus vector, recombinant virus, medicinal composition and application |
| 01/14/2014 | US8629088 Mixture of at least two fusion proteins, the production thereof and the use of the same |
| 01/14/2014 | CA2426312C Compositions and methods for modulating rsv infection and immunity |
| 01/09/2014 | WO2014008382A1 Materials and methods for jc polyomavirus propagation and detection |
| 01/09/2014 | WO2014007858A1 Modified adeno-associated virus vector compositions |
| 01/09/2014 | WO2014006146A1 Means and methods to increase adenovirus production |
| 01/09/2014 | WO2014005959A1 Complexes of cytomegalovirus proteins |
| 01/09/2014 | WO2013183863A9 Method for controlling expression of entire protein through base modification of 3' region |
| 01/09/2014 | US20140011260 Pol i promoter derived from vero cells and recombinant vector containing same |
| 01/09/2014 | US20140011188 Methods for producing virus particles with simplified glycosylation of surface proteins |
| 01/09/2014 | US20140010841 Attenuated Recombinant Alphaviruses Incapable of Replicating in Mosquitoes and Uses Thereof |
| 01/09/2014 | CA2878401A1 Modified adeno-associated virus vector compositions |
| 01/09/2014 | CA2878344A1 Complexes of cytomegalovirus proteins |
| 01/09/2014 | CA2877948A1 Paramyxovirus and methods of use |
| 01/08/2014 | EP2682749A1 Method for detecting analyte, and measuring kit |
| 01/08/2014 | EP2682459A1 Oncolytic adenovirus for target therapy of human tumor and use thereof |
| 01/08/2014 | EP2681232A1 Infectious bronchitis virus (ibv) spike protein as subunit vaccine |
| 01/08/2014 | EP2680867A2 Enhanced tumor therapy by tumor stem cell targeted oncolytic viruses |
| 01/08/2014 | CN103502263A Methods for isolating and quantifying antigen from vaccines |
| 01/08/2014 | CN103497967A Construction method and use of duck enteritis virus bacterial artificial chromosome |
| 01/08/2014 | CN103497934A Avian infectious bronchitis virus vaccine strain (HF2 strain) and application thereof |
| 01/08/2014 | CN103497933A Application of H9N2 type avian influenza virus strain in vaccine development |
| 01/08/2014 | CN103497236A Specific heptapeptide targeting to WISP-1 protein and application thereof |
| 01/08/2014 | CN103495162A Preparation method of porcine reproductive and respiratory syndrome compound inactivated vaccine |
| 01/08/2014 | CN103495158A Specific chronic myelogenous leukemia epitope vaccine for human leukocyte antigen (HLA) of Chinese population |
| 01/08/2014 | CN102807972B Hepatitis A virus purification method |
| 01/08/2014 | CN102492661B Preparation method and application of immunization preparation for controlling novel duck reovirus |
| 01/08/2014 | CN102199608B Efficient expression of pinellia ternate agglutinin (PTA) in bombyx mori reactor |
| 01/08/2014 | CN102168070B Human laryngeal epithelium cancer cell as well as preparation method and application thereof |
| 01/07/2014 | US8624080 Plant virus-based inducible expression system |
| 01/07/2014 | US8623379 Compositions and methods for generating an immune response |
| 01/03/2014 | WO2014004103A1 Methods for inactivating viruses during a protein purification process |
| 01/03/2014 | WO2014001504A2 Culture of bacteriophage |
| 01/03/2014 | WO2014000026A1 Recombinant viral vectors and uses therefor |
| 01/02/2014 | US20140004590 Thioxothiazolidine inhibitors |
| 01/02/2014 | US20140004568 Method of Viral Production in Cells |
| 01/02/2014 | US20140004147 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses |
| 01/02/2014 | US20140004143 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 01/01/2014 | EP2679683A2 Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same |
| 01/01/2014 | EP2679675A1 Mycovirus, phytopathogenic fungus, plant disease controlling agent, method for controlling plant disease, and method for attenuating phytopathogenic fungus |
| 01/01/2014 | EP2679596A1 HIV-1 env glycoprotein variant |
| 01/01/2014 | CN103492557A Method of purifying viruses using gel permeation chromatography |
| 01/01/2014 | CN103492556A Mycovirus, phytopathogenic fungus, plant disease controlling agent, method for controlling plant disease, and method for attenuating phytopathogenic fungus |
| 01/01/2014 | CN103484435A Porcine reproductive and respiratory syndrome virus protectant and application method thereof |
| 01/01/2014 | CN103484368A Operation pipe system for cell factory and application thereof |
| 01/01/2014 | CN103479997A Preparation method for avian reovirus virus water-in-oil-in-water type inactivated vaccines |
| 01/01/2014 | CN102676415B Genetic manipulation system based on Hfx. mediterranei and pyrF gene and its application |
| 01/01/2014 | CN102633869B Low temperature resistance associated protein and encoding gene and application thereof |
| 01/01/2014 | CN102559616B Norovirus RNA fragment-containing pseudoviral particle and preparation method thereof |
| 01/01/2014 | CN102477092B Protein used for controlling anthocyanidin content, coding gene thereof, and application thereof |
| 01/01/2014 | CN102297967B Surface plasma resonance detecting method for PVY/CMV (Potato Virus Y/Cucumber Mosaic Virus) |
| 12/31/2013 | US8618275 Efficient cell culture system for hepatitis C virus genotype 5A |
| 12/31/2013 | US8617869 Metal coated virus-based nanoelectrodes and method of assembling of same |
| 12/31/2013 | US8617805 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 12/31/2013 | US8617533 Multi-antigenic alphavirus replicon particles and methods |
| 12/31/2013 | CA2604691C Method for porcine circovirus production and assays for monitoring production |
| 12/31/2013 | CA2478371C Compositions and methods for generating an immune response |
| 12/27/2013 | WO2013192604A1 Purification of virus like particles |
| 12/27/2013 | WO2013192144A2 Rift valley fever virus replicon particles and use thereof |
| 12/27/2013 | WO2013191363A1 Novel bacteriophage, and use for inhibiting proliferation of pathogenic bacteria |
| 12/27/2013 | WO2013188918A1 Improved recombinant viruses |
| 12/26/2013 | US20130344570 Methods for viral inactivation and other adventitious agents |
| 12/26/2013 | US20130344569 Permanent human cell lines for the production of influenza viruses |
| 12/26/2013 | US20130344108 Inactivated poliovaccine |
| 12/25/2013 | EP2675476A1 Commercial scale process for production of prrsv |
| 12/25/2013 | EP2675475A2 Novel european prrsv strain |
| 12/25/2013 | EP2522719B1 Influenza hemagglutinin and neuraminidase variants |
| 12/25/2013 | CN103476399A Drug delivery particles and method for producing same |
| 12/25/2013 | CN103468653A Method for purifying type 71 enterovirus |
| 12/25/2013 | CN103468652A Method used for purifying FITC labeled prawn white spot syndrome virus (WSSV) |
| 12/25/2013 | CN103468651A Recombination Newcastle vaccine strain rAI4-S1 for expressing infectious bronchitis virus S1 protein and generating method thereof |
| 12/25/2013 | CN103468650A Application of human embryonic lung fibroblast strains in preparation of rabies inactivated vaccine |
| 12/25/2013 | CN103468649A Rapid adaptation method of rabies vaccine virus strains for human body on diploid cells of human body |
| 12/25/2013 | CN103468648A Method for culturing porcine epidemic diarrhea viruses by utilizing riptide bioreactor |
| 12/25/2013 | CN103468647A Swine flu H1N1 and H3N2 subtype bivalent inactivated vaccine |
| 12/25/2013 | CN103468646A Method for efficiently screening low-temperature bacteriophages |
| 12/25/2013 | CN103468645A Pseudorabies virus, pseudorabies vaccine and preparation method of pseudorabies vaccine |
| 12/25/2013 | CN103467581A Influenza virus M1 protein, and encoding gene and application of influenza virus M1 protein |
| 12/25/2013 | CN102807970B Canine distemper virus (CDV) sensitive cell line and establishment method and application thereof |
| 12/25/2013 | CN102743749B Method for preparing live attenuated rubella vaccine in human diploid cells by using basket-type bioreactor |
| 12/25/2013 | CN102727879B Spinner bottle production method of inactivated singapore grouper iridovirus (SGIV) vaccine |
| 12/25/2013 | CN102604898B VP60 protein recombinant baculovirus carrying type O foot and mouth disease virus B cell epitope |
| 12/25/2013 | CN102277368B Duck enteritis virus infectious recombinant cloning system and construction method and application thereof |
| 12/25/2013 | CN101809144B Method for producing flu virus |
| 12/24/2013 | US8614090 Astrovirus species |
| 12/24/2013 | US8614082 Attenuation of encephalitogenic alphavirus and uses thereof |
| 12/24/2013 | US8613935 Influenza hemagglutinin and neuraminidase variants |
| 12/24/2013 | US8613934 Cellular and viral inactivation |
| 12/24/2013 | CA2682108C Methods for generating high titer helper-free preparations of recombinant aav vectors |